Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis (2017) Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Erber R, Iro H, et al. Journal article Electronic Support for Retrospective Analysis in the Field of Radiation Oncology: Proof of Principle Using an Example of Fractionated Stereotactic Radiotherapy of 251 Meningioma Patients (2017) Rutzner S, Fietkau R, Ganslandt T, Prokosch HU, Lubgan D Journal article Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients (2017) Jeßberger J, Erlenbach-Wuensch K, Posselt R, Haderlein M, Agaimy A, Fietkau R, Hartmann A, Distel L Journal article Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells (2016) Derer A, Spiljar M, Baeumler M, Hecht M, Fietkau R, Frey B, Gaipl U Journal article Impact of radiotherapy and chemotherapy on PD-L1 and EGF-R expression in melanoma and glioblastoma cells (2016) Bäumler M, Spiljar M, Frey B, Fietkau R, Gaipl U, Derer A Conference contribution, Abstract of a poster Response to 6 cycles of chemotherapy with FOLFIRINOX is predictive of overall survival in patients with locally advanced unresectable pancreatic cancer (2016) Haderlein M, Lubgan D, Lettmaier S, Semrau S, Wolf W, Golcher H, Hohenberger W, Fietkau R Conference contribution Effective long-term local results and prognostic factors after fractionated stereotactic radiotherapy of 257 intracranial meningeoma (2016) Lubgan D, Rutzner S, Semrau S, Lambrecht U, Roessler K, Buchfelder M, Fietkau R Conference contribution Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution Tumor infiltrating cells - cell-to-cell distances enable differentiation between functionally active and suppressed inflammatory cells (2016) Distel L, Nagl S, Fietkau R, Haas M Conference contribution